Physician profile
Michael Moore
NPI 1306136452
$2,088.01
in general payments reported to CMS, 2019-2025
10 companies · $91.63 in 2025
The $91.63 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $78.08 · 2021: $44.13 · 2022: $293 · 2023: $323 · 2024: $1,258 · 2025: $91.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $886 · Travel and Lodging: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $886.11 |
| Travel and Lodging | $786.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,684.20 | 2021-2025 | Unid_pass, Mazor X System, Catalyft Pl Expandable Interbody System |
| Monteris Medical Corporation | $146.40 | 2022 | |
| Medexus Pharma, INC. | $100.80 | 2024 | Gleolan |
| Surgical Theater. INC. | $33.56 | 2023 | |
| Stryker Corporation | $26.60 | 2024 | Optablate |
| Medtronic USA, INC. | $24.20 | 2020 | |
| Integra Lifesciences Corporation | $22.72 | 2020 | |
| Abbott Laboratories | $19.82 | 2020 | |
| Goode Surgical INC | $18.37 | 2025 | |
| Covidien Lp | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.